icon-folder.gif   Conference Reports for NaTaP  
 
  EASL - The International Liver Congress 2015
50th annual Meeting of the European
association for the Study of the Liver
Vienna, austria  april 22-26
Back grey_arrow_rt.gif
 
 
 
The Pharmacokinetics of Beclabuvir (BMS-791325) When Administered in Combination With Daclatasvir and Asunaprevir in Treatment-naive Patients With or Without Cirrhosis Infected With HCV Genotype 1
 
 
  Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
 
He B, Sims K, Chung E, Luo W-L, Pursley J, Wind-Rotolo M, LaCreta F, Bertz R, AbuTarif M Bristol-Myers Squibb Research and Development, Princeton, NJ, USA

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif